The University of Southampton
University of Southampton Institutional Repository

Indirect impact of the COVID-19 pandemic on activity and outcomes of transcatheter and surgical treatment of aortic stenosis in England

Indirect impact of the COVID-19 pandemic on activity and outcomes of transcatheter and surgical treatment of aortic stenosis in England
Indirect impact of the COVID-19 pandemic on activity and outcomes of transcatheter and surgical treatment of aortic stenosis in England

Background: Aortic stenosis requires timely treatment with either surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). This study aimed to investigate the indirect impact of coronavirus disease 2019 (COVID-19) on national SAVR and TAVR activity and outcomes. Methods: The UK TAVR Registry and the National Adult Cardiac Surgery Audit were used to identify all TAVR and SAVR procedures in England, between January 2017 and November 2020. The number of isolated aortic valve replacement (AVR), AVR+coronary artery bypass graft surgery, AVR+other surgery, and TAVR procedures per month was calculated. Separate negative binomial regression models were fit to monthly procedural counts, with functions of time as covariates, to estimate the expected change in activity during COVID-19. Results: We included 15 142 TAVR cases, 13 357 isolated AVR cases, 8550 AVR+coronary artery bypass graft cases, and 6773 AVR+other cases. Before March 2020 (UK lockdown), monthly TAVR activity was rising, with a slight decrease in the SAVR activity during 2019. We observed a rapid and significant drop in TAVR and SAVR activity during the COVID-19 pandemic, especially for elective cases. Cumulatively, over the period March to November 2020, we estimated an expected 4989 (95% CI, 4020-5959) cases of aortic stenosis who have not received treatment. Conclusions: This study has demonstrated a significant decrease in TAVR and SAVR activity in England following the COVID-19 outbreak. This situation should be monitored closely, to ensure that monthly activity rapidly returns to expected levels. There is potential for significant backlog in the near-to-medium term and potential for increased mortality in this population.

Aged, Aged, 80 and over, Aortic Valve Stenosis/surgery, COVID-19/epidemiology, England, Female, Heart Valve Prosthesis, Humans, Male, Middle Aged, Procedures and Techniques Utilization, Registries, Transcatheter Aortic Valve Replacement/statistics & numerical data, Treatment Outcome
1941-7640
e010413
Martin, Glen P.
684844de-edeb-4ef8-9a5f-7c3f35b09cb4
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Goodwin, Andrew T.
038853cd-0e36-42bf-b715-5772b0c010eb
Nolan, James
1cdb1e12-958f-4b04-a730-242dd48591b1
Balacumaraswami, Lognathen
4f996f79-c66f-4829-a19e-c01c6a44b112
Ludman, Peter F.
ed96bc44-311b-4a55-88d9-ce83bab3e791
Kontopantelis, Evangelos
0a21ca6f-4516-45f8-80fc-b10dd7db6780
Wu, Jianhua
d1e83015-b7d2-4404-847e-c6f73e281759
Gale, Chris P.
96b5706c-fd86-4b41-9568-3d917ef2c805
de Belder, Mark A
3d0eff51-f1d1-41a7-aac1-e193db082360
Mamas, Mamas A.
41515b72-75ff-4922-bb9f-8f9c63f9f5af
Martin, Glen P.
684844de-edeb-4ef8-9a5f-7c3f35b09cb4
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Goodwin, Andrew T.
038853cd-0e36-42bf-b715-5772b0c010eb
Nolan, James
1cdb1e12-958f-4b04-a730-242dd48591b1
Balacumaraswami, Lognathen
4f996f79-c66f-4829-a19e-c01c6a44b112
Ludman, Peter F.
ed96bc44-311b-4a55-88d9-ce83bab3e791
Kontopantelis, Evangelos
0a21ca6f-4516-45f8-80fc-b10dd7db6780
Wu, Jianhua
d1e83015-b7d2-4404-847e-c6f73e281759
Gale, Chris P.
96b5706c-fd86-4b41-9568-3d917ef2c805
de Belder, Mark A
3d0eff51-f1d1-41a7-aac1-e193db082360
Mamas, Mamas A.
41515b72-75ff-4922-bb9f-8f9c63f9f5af

Martin, Glen P., Curzen, Nick, Goodwin, Andrew T., Nolan, James, Balacumaraswami, Lognathen, Ludman, Peter F., Kontopantelis, Evangelos, Wu, Jianhua, Gale, Chris P., de Belder, Mark A and Mamas, Mamas A. (2021) Indirect impact of the COVID-19 pandemic on activity and outcomes of transcatheter and surgical treatment of aortic stenosis in England. Circulation. Cardiovascular interventions, 14 (5), e010413. (doi:10.1161/CIRCINTERVENTIONS.120.010413).

Record type: Article

Abstract

Background: Aortic stenosis requires timely treatment with either surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). This study aimed to investigate the indirect impact of coronavirus disease 2019 (COVID-19) on national SAVR and TAVR activity and outcomes. Methods: The UK TAVR Registry and the National Adult Cardiac Surgery Audit were used to identify all TAVR and SAVR procedures in England, between January 2017 and November 2020. The number of isolated aortic valve replacement (AVR), AVR+coronary artery bypass graft surgery, AVR+other surgery, and TAVR procedures per month was calculated. Separate negative binomial regression models were fit to monthly procedural counts, with functions of time as covariates, to estimate the expected change in activity during COVID-19. Results: We included 15 142 TAVR cases, 13 357 isolated AVR cases, 8550 AVR+coronary artery bypass graft cases, and 6773 AVR+other cases. Before March 2020 (UK lockdown), monthly TAVR activity was rising, with a slight decrease in the SAVR activity during 2019. We observed a rapid and significant drop in TAVR and SAVR activity during the COVID-19 pandemic, especially for elective cases. Cumulatively, over the period March to November 2020, we estimated an expected 4989 (95% CI, 4020-5959) cases of aortic stenosis who have not received treatment. Conclusions: This study has demonstrated a significant decrease in TAVR and SAVR activity in England following the COVID-19 outbreak. This situation should be monitored closely, to ensure that monthly activity rapidly returns to expected levels. There is potential for significant backlog in the near-to-medium term and potential for increased mortality in this population.

This record has no associated files available for download.

More information

Accepted/In Press date: 26 January 2021
e-pub ahead of print date: 18 May 2021
Published date: May 2021
Additional Information: Publisher Copyright: © 2021 American Heart Association, Inc.
Keywords: Aged, Aged, 80 and over, Aortic Valve Stenosis/surgery, COVID-19/epidemiology, England, Female, Heart Valve Prosthesis, Humans, Male, Middle Aged, Procedures and Techniques Utilization, Registries, Transcatheter Aortic Valve Replacement/statistics & numerical data, Treatment Outcome

Identifiers

Local EPrints ID: 511042
URI: http://eprints.soton.ac.uk/id/eprint/511042
ISSN: 1941-7640
PURE UUID: d50c6e92-1a12-4b66-8d44-7b4f8abdd9c0
ORCID for Nick Curzen: ORCID iD orcid.org/0000-0001-9651-7829

Catalogue record

Date deposited: 29 Apr 2026 16:38
Last modified: 30 Apr 2026 01:39

Export record

Altmetrics

Contributors

Author: Glen P. Martin
Author: Nick Curzen ORCID iD
Author: Andrew T. Goodwin
Author: James Nolan
Author: Lognathen Balacumaraswami
Author: Peter F. Ludman
Author: Evangelos Kontopantelis
Author: Jianhua Wu
Author: Chris P. Gale
Author: Mark A de Belder
Author: Mamas A. Mamas

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×